USP stevia reference standards available
This article was originally published in The Tan Sheet
Executive Summary
U.S. Pharmacopeia publishes reference standards for stevia-based ingredients rebaudioside A and stevioside, against which food manufacturers can compare their own stevia supply. The standards "provide a powerful tool to help ensure the authenticity of the ingredients," an executive for the nonprofit standard-setting organization said in a June 1 release. USP said it expects to publish its written testing standard for high-purity rebaudioside A in the Food Chemicals Codex August 31. The monograph for the sweetener, used in Cargill's Truvia and Merisant's PureVia, was made available for comment in January (1"The Tan Sheet" Jan. 12, 2009, In Brief)
You may also be interested in...
USP sets stevia standard
The U.S. Pharmacopeial Convention posts a final monograph for the stevia-based sweetener rebaudioside A, which is available for comment on USP's Food Chemicals Codex forum until March 31. Rebaudioside A is in Cargill's Truvia and Merisant's PureVia (1"The Tan Sheet" Dec. 22, 2008, p. 8). A USP official says Jan. 6 that one of the companies submitted the "straw man" monograph, likely because of determinations of rebaudioside A's safety (2"The Tan Sheet" Nov. 3, 2008, p. 7). The proposed standard assures that rebaudioside A is high quality, free of contaminants and consistent. USP intends to publish the monograph in the 2009 FCC supplement
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.